[Zygomycosis (mucormycosis) in patients with haematologic malignancy]

Ugeskr Laeger. 2011 Jan 31;173(5):353-4.
[Article in Danish]

Abstract

Zygomycosis is an invasive and increasingly emerging life-threatening infection. Diabetes is the most common risk factor; however, zygomycosis has increased among patients with haematologic malignancy, which is now the second most common risk factor with an incidence of 16%. Rapid diagnosis and treatment are essential for patient survival. In the Danish literature, only a few cases have been reported. We present two cases of zygomycosis, both with a fatal outcome, and we discuss the pathogenesis and treatment of invasive zygomycosis.

Publication types

  • Case Reports

MeSH terms

  • Absidia / isolation & purification
  • Adult
  • Brain / diagnostic imaging
  • Brain / pathology
  • Fatal Outcome
  • Female
  • Humans
  • Immunocompromised Host
  • Leukemia, Myeloid, Acute / complications*
  • Lymphoma, T-Cell / complications*
  • Male
  • Middle Aged
  • Mucormycosis / drug therapy
  • Mucormycosis / etiology*
  • Mucormycosis / pathology
  • Rhizopus / isolation & purification
  • Risk Factors
  • Tomography, X-Ray Computed